Anticoagulation and Circuit Management
Key Takeaways
- Unfractionated heparin is standard systemic anticoagulation to prevent dialyzer and line clotting during HD.
- Heparin dosing is individualized by weight, access type, and bleeding risk; hold or reduce for active bleeding.
- Protamine sulfate reverses heparin in emergent bleeding but is used cautiously due to hypersensitivity risk.
- Citrate regional anticoagulation may be used for high bleeding-risk patients in some settings.
- Post-treatment hemostasis assessment detects excessive anticoagulation at needle sites.
Anticoagulation and Circuit Management
Quick Answer: Heparin prevents clotting in the extracorporeal circuit during HD; doses are individualized, reduced when bleeding risk is high, and protamine reverses heparin in selected emergencies—nurses monitor access sites and labs for hemorrhage.
Contact between blood and artificial surfaces activates coagulation. Without anticoagulation, the dialyzer and lines clot within minutes, wasting access, blood, and treatment time. CDN exam content emphasizes heparin pharmacology, nursing hold parameters, circuit troubleshooting, and post-treatment bleeding assessment—not intensivist-level anticoagulation protocols.
Heparin Mechanism and Dosing
Unfractionated heparin (UFH) potentiates antithrombin III, inhibiting thrombin and factor Xa. HD facilities typically administer a loading dose at connection followed by a maintenance infusion through the arterial blood line or machine syringe pump. Doses scale to weight, access type (catheters may need more), and bleeding risk.
Common nursing orders include standard heparinization, low-dose heparin, and tidal or no-heparin treatments for patients with active GI bleeding, recent surgery, or severe thrombocytopenia. No-heparin HD uses frequent saline flushes and higher transmembrane pressure tolerance limits—clearance may still be delivered with vigilant monitoring.
| Patient situation | Typical anticoagulation approach |
|---|---|
| Standard HD, no bleeding risk | Loading + maintenance heparin |
| Recent surgery / active bleeding | Hold or minimize heparin; saline flush protocol |
| Heparin-induced thrombocytopenia (HIT) | No heparin; alternative per nephrologist |
| High bleeding risk with needed HD | Regional citrate or minimal systemic heparin |
Worked scenario: A patient on HD has hematemesis admitted from the waiting room. The nephrologist orders HD without heparin for volume and potassium management. The nurse primes carefully, flushes per protocol, watches for rising TMP indicating clot, and extends pressure monitoring. CDN trap: stopping HD entirely may be unsafe if hyperkalemia or pulmonary edema is life-threatening—anticoagulation is modified, not safety steps ignored.
Regional Citrate and Alternative Agents
Regional citrate anticoagulation chelates ionized calcium in the circuit, preventing clotting with less systemic effect when configured correctly. It requires calcium repletion monitoring and specialized protocols—more common in CRRT but may appear conceptually on CDN. Low-molecular-weight heparin is occasionally prescribed; nursing implications include longer half-life and limited protamine reversal.
Circuit Clotting Signs and Management
Early clot signals include rising venous pressure, increasing TMP, darkening blood in the venous chamber, and reduced line recirculation. Partial clot reduces delivered dose—post-BUN may be inadequate even if treatment appears complete. Complete clot stops blood flow and triggers alarms.
Interventions per protocol: saline flush, increase heparin on next treatment if appropriate, review Qb relative to access flow, and notify nephrologist for recurrent events. Never increase heparin unilaterally when bleeding is present.
| Sign | Likely cause | Nursing action |
|---|---|---|
| Rising TMP mid-treatment | Dialyzer clot forming | Flush, monitor; prepare circuit change |
| Dark venous chamber | Clot propagation | Notify MD; may need new dialyzer |
| Falling delivered Qb | Access or circuit obstruction | Assess needles, pressures |
| Repeated clotting | Low antithrombin, stenosis | Physician workup |
Bleeding Risk and Protamine
Post-cannulation bleeding beyond 10–15 minutes may indicate excess heparin, vessel injury, or uremic platelet dysfunction. Apply pressure, elevate arm, and consult per protocol. Access site bleeding after HD should be controllable with pressure dressings.
Protamine sulfate neutralizes heparin in emergent bleeding or heparin overdose—slow IV infusion with risk of hypotension, bradycardia, and anaphylaxis. CDN items test indication (heparin reversal), not detailed dosing math. It is ineffective for low-molecular-weight heparins.
Extracorporeal Volume and Blood Return
At treatment end, saline push or fluid replacement mode returns blood in the circuit to the patient, minimizing anemia. Know machine-specific blood return volume (often 100–250 mL). Sudden disconnect during return risks air embolism—clamp arterial then venous lines per training.
Hemostasis assessment: prolonged oozing after needle removal may require pressure dressing adjustment and communication about reducing next heparin dose—document minutes to hemostasis.
No-Heparin Protocol Essentials
Saline flushes every 15–30 minutes, maintain adequate Qb (often ≥250–300 mL/min), limit treatment time if TMP rises, and have spare dialyzer available. Patients still need full UF and adequacy when clinically stable—clotting off early wastes a session.
Documentation
Document heparin dose delivered, any holds, clotting events, TMP trends, and hemostasis time. Recurrent clotting with adequate heparin suggests antithrombin III deficiency or access stenosis—physician follow-up required.
Exam Traps
- Heparin prevents circuit clot, not access thrombosis long-term—access patency is separate surveillance.
- No-heparin HD still requires monitoring for clot—not "safer" if treatment repeatedly clots off.
- Protamine reverses heparin, not warfarin or direct oral anticoagulants.
- Extended bleeding after HD may mean reduce next heparin dose—document and communicate.
- Active GI bleed + hyperkalemia = modified anticoagulation, not automatic cancellation of HD.
HIT and Alternative Anticoagulation
Heparin-induced thrombocytopenia (HIT) presents with thrombocytopenia and thrombosis risk despite heparin exposure—never administer heparin if HIT is suspected or confirmed. Alternative agents (argatroban, bivalirudin) require nephrology and pharmacy coordination; CDN items test recognition, not titration math.
Catheter Lock Solutions
CVC lock solutions (heparin or citrate) differ from systemic circuit heparin—do not confuse catheter maintenance doses with treatment anticoagulation orders. Infected catheters may require lock solution changes per protocol.
Anticoagulation balances circuit patency against hemorrhage—CDN nurses must recognize when the prescription changes but dialysis remains urgent.
What is the primary reason heparin is administered during standard hemodialysis?
A patient with active gastrointestinal bleeding requires urgent HD for hyperkalemia. The nephrologist orders HD without systemic heparin. The nurse should:
Rising transmembrane pressure (TMP) during HD most often warns of:
Protamine sulfate is indicated in which dialysis-related situation?